Posted in | News | Signal Processing

RADA Announces Sale of MHR-Based RPS-42 Aerial Surveillance Radar Systems to an Asian Country

RADA Electronic Industries of Netanya, Israel announced today the sale of mobile air surveillance radar systems to an Asian country.

The total contract value of the sale is approximately $2 million and deliveries are expected during 2016. RADA’s Multi-Mission Hemispheric Radar (MHR) based RPS-42 aerial surveillance radar systems will be installed on tactical vehicles and will provide a mobile air surveillance solution to the customer's armed forces.

The MHR radar platform, which in the heart of the system, is an S-band, software-defined, pulse-Doppler, active electronically scanned array radar. The radar system introduces sophisticated beam forming capabilities and advanced signal processing, can provide multiple missions on each radar platform, and offers unprecedented performance-to-price ratio. It is compact and mobile, delivering ideal organic, tactical surveillance solutions for force and border protection applications such as counter rockets and mortars, counter unmanned aerial systems, ground moving target indicator, air surveillance and more.

According to Zvi Alon, RADA's CEO, "We are very pleased with this award, which is our first production contract of radars from this part of the world. It re-emphasizes all the qualities that our radars present to the end user: superior performance to price ratio, compactness and mobility, automated operation, and above all – performance that meets the present day needs of our customers."

Source: http://www.rada.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.